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Abstract 
Objective 
Medication related problems (MRP) are common for older adults and can lead to harm.  The 
older person’s perspective on MRP has been seldom reported in published literature. This 
study explored the lived experience of MRP in older adults with varying functional levels, 
focussing on the hospital discharge period.         
Design, setting, participants 
This qualitative study was conducted in Brighton and Hove, UK.  A purposive sample of 20 
older people with experience of MRP, involving carers, took part in focus groups and semi-
structured interviews. Data were thematically analysed using a ‘framework’ approach.  
Results 
Four major themes associated with MRP were identified; (1) experience of the healthcare 
system, (2) practicalities of using medicines, (3) management of medication problems, and, 
(4) participant beliefs.  Participants encountered problems in communication with 
healthcare professionals such as passive listening and paternalistic consultations. A conflict 
was acknowledged between participants’ implicit trust in the healthcare system and their 
negative experience of MRP.  Participants felt vulnerable around hospital discharge, 
describing reduced capacity to comprehend information, pressured discharge 
circumstances, and lack of integrated care in the community.  Drug formulations, packaging 
and information leaflets were felt to be poorly tailored to the needs of older people.  
Conclusions  
The lived experience of older people with MRP in this study was multifaceted and complex.  
Participants felt communication was poor around hospital discharge, and insufficient 
support with medicines was offered in the community when problems arose.  Harm due to 
MRP might be reduced if the contributory factors described by patients inform clinical and 
policy-level intervention.  
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Introduction 
Polypharmacy and medication-related harm are increasing in England. [1,2] The period 
following hospital discharge is a time when older people are at highest risk; one in three 
experience medication-related harm within eight weeks post-discharge.[3]   
Although medication-related problems (MRP) are an important cause of harm, there has 
been little research to understand its impact from the older person’s view point.  The 
patient perspective is crucial in effectively translating clinical research to ‘real-world’ 
settings [4,5].  For instance, in the Canadian EMPOWER trial of patient education to support 
withdrawal of benzodiazepines in older users[6], the patient perspective was pivotal to 
understand the patient-provider context necessary for successful deprescribing [7].  
The aim of this study was to explore the lived experience of MRP amongst older adults in a 
UK community setting.  Given the increased risk of MRP following hospital discharge, we 
designed the study to elicit participant views around this critical time.  
  
 
Methods  
Full methods are described in appendix 1 online.  Three focus groups and eight semi-
structured interviews were conducted using topic guides with a purposive sample including 
both independent and housebound older adults in Brighton and Hove, UK.  Participants 
were recruited through Age-UK Brighton and Hove (AUKBH).  Data collection took place 
between October 2016 and January 2017 until data saturation (defined as no new themes 
being elicited).[8] Data were analysed thematically using a Framework approach, developed 
by the National Centre for Social Research, particularly suited to multidisciplinary research 
teams. [9,10]  This approach involves five processes: data familiarisation, coding, indexing, 
charting, and interpretation.  
  
Results 
Participants 
Twenty participants were included (see appendix 2 online), 14 females, median age 78 years 
(range 65 to 98 years), all Caucasian. Twelve independent older adults, recruited from 
AUKBH activity groups, participated in three focus groups.  The remaining eight participants 
(six housebound individuals and two informal carers) were recruited from a support service 
offered by AUKBH for recently discharged patients and interviewed at home.  
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The mean number of prescribed medicines amongst all participants was 5 (SD 3.6, range 0-
12).  However the mean was 8 medicines amongst housebound individuals.  Nine 
participants had a hospital admission in the past year.  
 
Key findings 
Participants’ experience of MRP around hospital discharge is summarised in Figure 1.  The 
range of ‘side-effects’ described can be seen in appendix 3 online.   
 Figure 1. Experiences of MRP amongst participants 
 
 
 
Four major themes associated with MRP were identified: experience of the healthcare system, practicalities 
of using medicines, management of medication problems, and participant beliefs (see Table 2). 
Experience of the healthcare system 
Participants reported poor communication with health professionals and between professionals.  In some 
cases, participants described passive listening and failure of doctors to respond when harm was reported.  
Discussion about MRP with General Practitioners (GP) often took place over the telephone due to lack of 
face-to-face appointments, limiting the quality of communication and capacity of GPs to fully address the 
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problem.  None of the participants felt involved in medication-related decisions.  In response to adverse 
events, some participants reported changes in their own behaviour (e.g. asking a standard set of questions 
about any new medicine), to ensure they understand the rationale for medication-related decisions.   
The transition from hospital to home was considered a particularly vulnerable time due to ongoing recovery 
from illness, a reduced capacity to retain information provided at the point of discharge, and a lack of 
community follow-up.  Changes made to regular medicines whilst in hospital contributed to participants’ 
confusion and poor adherence when back in their own homes. Pharmacists were mentioned as a valuable 
support in the community, offering more time compared to GPs about medication-related concerns, and, 
identifying prescribing errors.     
Practicalities of using medicines 
Many participants experienced difficulties with medicine formulation, packaging and/or instructions. They 
felt that medicines themselves were not tailored to meet the needs of an older person, with tablets such as 
aspirin being too small to handle and other medicines such as calcium/vitamin D combinations being too 
large to swallow.  These problems were especially noted in the context of visual impairment or manual 
dexterity.  One participant made the analogy between such difficulties in older people and that seen in 
children, ‘…imagine giving a big pill like that to a kid’. 
Medication compliance aids (MCA) e.g. blister packs, were broadly felt to be helpful despite difficulties 
removing tablets which sometimes necessitated use of sharp instruments to cut into each pocket.  A major 
concern was the inconsistency in the colour and shape of medicines placed in the MCAs from one week to 
another.  Other challenges included packaging I foreign languages and discrepancies in the listed drug 
interactions for the same drug by different manufacturers. 
 
Management of medication problems 
Whilst some participants sought medical attention for MRP, many chose not to due to perceived lack of 
time of the GP, or, fear of being a ‘nuisance’.  Self-management of MRP was attempted using medical books, 
the online British National Formulary, newspapers articles, and the advice of friends or family.  ‘Trial and 
error’ adjustment of medicines to overcome adverse effects, without consulting prescribers, was a common 
approach.  One lady expressed the need to suffer side-effects as her ‘body had to get used to it’.  
  
Participant beliefs 
A prominent sub-theme was the older person’s misinformed risk to benefit calculations, with several 
participants describing a poorer quality of life due to MRP as a necessary trade-off for additional life years.  
There was a tension between the participants’ expectations of medical treatment, based on implicit trust in 
their doctors, and their adverse lived experiences.  One participant said ‘they must help if the doctor gives 
 5 
them to you…but they’re not, not in my body’.  
 
 
Table 2. Illustrative data extracts by thematic categories and key sub-themes  
Categories Sub-themes Illustrative extracts 
Experience of the 
healthcare system 
 
Poor communication ‘I kept telling her (General Practitioner) I was getting more and more 
suicidal, I told her, and then all she said was “oh well, you’ve had these 
depressive states before”, which was nothing at all to do with these tablets 
(steroids), this was something different’ [P20, female, 84] 
‘When you're in hospital and you get prescribed these pills they don’t ever 
tell you what they are and what they’re for… they discuss things 
themselves and the patient is not involved, which is wrong...it’s like a 
secret society’ [P17, male, 75] 
 Inappropriate 
prescribing 
‘They’ll go back to the doctor and maybe see someone different and then 
say “oh I’ve got this wrong with me” and they might be given another drug 
but it’s not looked at that it might be the first drug that’s causing that 
problem.’ [P4, female, 69] 
 Hospital discharge 
support 
‘I come out and they give me a pile of medicine to take which I didn’t know 
what to do with and I had to get somebody, don’t know what it was, come 
around and sort out medicine for me… that was that, and that’s for 
afternoon and two of them, you know, ‘cos I didn’t know’ [P14, male, 82] 
‘The pharmacist came around and talked to her about it and explained it 
and everything, she was going to change one of the medicines, so she had 
a good story before she came out of hospital’ [P10, male, 74] 
Practicalities of using 
medicines 
 
Formulation, 
Packaging and 
instructions 
  
‘Sometimes the colour changes or the shape, and that does concern me 
because you know, I think have they made a mistake. It’s written on the 
side but it’s very difficult to work out, especially when your eyes are 
getting bad’ [P9, female, 85] 
‘Some pills they are huge…imagine giving a big pill like that to a kid’ [P17, 
male, 75] 
Management of 
medication problems 
 
Information and 
Support 
 
‘I suppose you could go to your doctor if you were worried to ask a few 
questions, but we're the sort of people that, you know, 'oh I'm afraid to go 
to the doctor’, you know, he's too busy to mess about just answering silly 
questions like that' [P19, female, 86] 
‘Got books here, ones on drugs.  And the other one, the other one, medical 
dictionary’ [P17, male, 75] 
 Non-Adherence ‘They said three a day but see they give me constipation, I know that 
much, they give me constipation, I take one at maximum a day’ [P14, 
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 male, 82] 
Participant beliefs 
 
Risk:Benefit analysis 
 
‘I suffered for a little while and then I made an appointment…I was just 
thinking that my body had to get used to it.’ [P9, female, 85] 
‘I’m now awake at night, it’s not life and death but it would be nice not to 
wake up itching all the time… I know I’ve got to take the tablets, because 
I’d like to be around for a little bit longer’ [P7, female, 72] 
 Conflict between 
expectation and 
experience 
 
‘Well you trust your doctor don’t you, I mean, you think they’re right and 
you take them but there was no way I felt depressed when I went to the 
doctors, I was in pain, my back was killing me’ [P13, female, 79] 
‘They’re telling you you know nothing, whereas you’re living it (medication 
problems) and you do know’ [P1, female, 79] 
 
 
 
Discussion 
 
To our knowledge, this is the first community-based study in England to explore the lived 
experience of older people with MRP. This study highlights key challenges associated with 
MRP that concern patients; poor communication with prescribers, vulnerability during the 
transition of care at hospital discharge, inconsistency in medicines information and 
packaging, side-effects, and, difficulties obtaining medical advice.  We acknowledge that our 
findings were based on the views of a Caucasian cohort in one UK city.  
Many of the practical problems with medication use highlighted in our study are common to 
older people in other European countries.[11]  The dispensing of medicines packaged in part 
English and part foreign text, and, inconsistent drug safety information between 
manufacturers are new insights. ‘Parallel imports’, where medicines are imported from 
countries outside of the UK and then sold and dispensed in the UK under a license from the 
Medicines and Healthcare products Regulatory Agency (MHRA), are used by pharmacies to 
reduce their purchase costs. [12] Our findings suggest that this is confusing and anxiety-
provoking for some older people, and the MHRA should consider how to tighten regulations 
around re-labelling to increase clarity for consumers.  Furthermore, product safety 
information should be standardised between manufacturers of the same drug. 
Participants reflected that doctors did not actively listen to their concerns of MRP, which 
directly led to harm in some instances.  A Dutch study of hospitalised patients found that 
approximately 80% of patient reports of ‘side-effects’ are accurate. [13] Thus a passive 
approach towards patient concerns of MRP is not clinically justifiable. The impact of 
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medication harm extends beyond the physical discomfort; older people in this study 
described erosion of their trust in the healthcare system and heightened anxiety about 
future medicines use.  The time taken in the short-term to elicit patient concerns and 
proactively respond to these could save substantially on time and cost required in the 
longer term to address poor adherence and medication harm.   
The patient-prescriber relationship is a key determinant of safe and effective medicines 
use[14].  Concordance is a patient-centred approach to consultation which gives primacy to 
the patient perspective within negotiated medication-related decisions[15].  This approach 
re-orientates communication from paternalistic consultation, as experienced by our 
participants, to collaboration and consensus-built decisions which can better meet both the 
patient and provider’s expectations of treatment [15,16].  
Adequate information provision is crucial to shared decision making [17] and informed 
consent to treatment.  Doctors struggle with the balance required in providing sufficient 
information of potential medication risk and causing undue fear. [18–20] Older people in 
this study sought clear and contextualised information at their level of comprehension of 
the medicine indication, and an open discussion of the potential risks and benefits for them 
as individuals.  Our findings can generate a wider impact by supporting the case for 
enhanced medication counselling during pharmacist-led medication reviews at hospital 
discharge[21]. This would align with related national guidance[14,22], and might lead to 
reduction in MRP. 
 
 
Conclusions  
Older people describe a heightened vulnerability to MRP around hospital discharge, and 
identify inadequate communication, uncoordinated processes, inappropriate prescribing, 
and poor drug formulation and packaging as important issues to address.  
Key Points 
 Comprehension of medicines-related information at hospital discharge is limited amongst 
older adults  
 Medication-related problems can erode the trust of patients in their doctors and the 
healthcare system   
 Non-adherence is used by some older adults as a protective measure to ameliorate 
medication-related harm 
 Medicines formulation and information should be better tailored to the needs of older 
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people 
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Appendix 1. Methods  
This study was approved by the Brighton and Sussex Medical School Research Governance 
and Ethics Committee (RGEC reference 16/041/ALI).   
This qualitative research using focus groups and semi-structured interviews was undertaken 
with older adults in the city of Brighton and Hove, UK. This study is reported in accordance 
with the standards published by O’Brien et al (2014), and patient and public involvement 
informed its design (see below).[8]  
We intentionally did not stipulate a definition of MRP to ensure that we explored MRP from 
the participant perspective.  
Patient and public involvement (PPI) 
Five older adults (one male, four females; all aged greater than 65 years) with previous 
experience of participatory research acted as advisors and supported the conceptualisation 
and design of this study, and provided input to the protocol, consent forms, participant 
information sheets and topic guides.  We held a round-table meeting in June 2016, and then 
continued correspondence with the PPI group through telephone meetings, email and 
letters.  The relevance of the study for patient benefit was explored and confirmed, and 
changes were made to the wording and length of the participant information sheet to 
improve readability and comprehension.  
 
Participants 
A purposive sample of ambulatory older adults, and dependent, housebound older adults 
were invited to participate in this study. Participants were recruited via a community 
organisation (Age UK Brighton & Hove) that runs activity groups, and, a ‘crisis’ service that 
gives social assistance and supports access to clinical help for older people following 
hospital discharge.  The study was advertised by the organisation’s activity group leader 
using posters (see example poster below), whilst participants recruited through the crisis 
service were invited to participate by the service manager.   Participants were included if 
they met the following eligibility criteria; (1) age 65 years, (2) has personal experience of 
taking regular medicines or caring for someone taking regular medicines, (3) has personal 
experience of MRP or caring for someone that has experienced MRP, (4) has personal 
experience of hospital discharge or caring for someone that has experienced hospital 
discharge, (5) does not have severe cognitive impairment as assessed by the service 
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managers.  Participants self-defined themselves as having experienced MRP as the research 
team intentionally did not specify an MRP definition (see participant information sheet 
below).  Written informed consent was taken from each participant.   
Data collection 
Three focus groups and eight semi-structured home interviews were conducted by the lead 
author using a topic guide (see topic guides below), lasting approximately 90 and 45 
minutes respectively. The focus groups and interviews were audio recorded and transcribed 
verbatim.  Data collection took place between October 2016 and January 2017 until data 
saturation (defined as no new themes being elicited) was achieved.[9]  
Framework thematic analysis 
A ‘framework’ approach to thematic data analysis was chosen due to its highly prescriptive 
methodology, which is particularly suited to multidisciplinary research teams such as 
ours.[10,11]  The framework approach, developed in the 1980s by the UK National Centre 
for Social Research, involves five key processes for data analysis; familiarisation, coding, 
indexing, charting, and interpretation.[10,11] Codes in this study were selected through a 
mixed deductive and inductive approach.[10] The deductive codes were pre-selected with 
reference to the interview topic guides used and further themes were generated inductively 
through an open coding process. Initial codes were suggested by all study authors based on 
individual familiarisation with two participant transcripts.  These were then discussed and 
consensus was reached on the codes to be adopted.  The remaining transcripts were coded 
based on this consensus, with new codes emerging inductively during the process of 
indexing the transcripts.  New codes were discussed and their relevance explored between 
the researchers to decide on adopting them.        
Codes were categorised into four meta-constructs of themes in relation to MRP, (1) 
experience of the healthcare system, (2) practicalities of using medicines, (3) managing MRP 
(4) participant beliefs.  Themes were then extracted from interrogating the data within the 
context of these categories and codes, after charting the data by participants and codes in a 
spreadsheet.  This matrix was then analysed by comparison within and between cases under 
columns of codes, in conjunction with brief field notes made immediately post-interviews, 
to extract meaning and data interpretation.  
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Appendix 2. Table of sample characteristics 
 
Participant number* Gender Age Ethnicity Last hospital 
admission 
Regular medicines (n) 
P1 Female 79 White British > 12 months ago 3 
P2 Female 68 White British > 12 months ago 0 
P3 Female 76 White British > 12 months ago 1 
P4 Female 69 White British > 12 months ago 0 
P5 Female 65 White British N/A N/A 
P6 Female 72 White British last 5-8 months 3 
P7 Female 72 White British > 12 months ago 3 
P8 Female 74 White British unknown 7 
P9 Female 85 White British last 9-12 months 6 
P10 Male 74 White British in last month 5 
P11 Male 74 White British last 9-12 months 2 
P12 Female 75 White British > 12 months ago 3 
P13 Female 79 White Irish in last month 11 
P14 Male 82 White British in last month 3 
P15 Female 79 White British > 12 months ago 8 
P16 Male 85 White British in last month 9 
P17 Male 75 White British > 12 months ago 7 
P18 Male 98 White British last 9-12 months 4 
P19 Female 86 White British N/A N/A 
P20 Female 84 White British last 1-4 months 12 
*P1 to P12 participated in focus groups. P13 to P20 were interviewed in their homes; P5 and P19 were interviewed as informal carers of 
older people with medication-related problems; P15 was interviewed in a dual role as an informal carer and individual that met eligibility 
for participation. 
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Appendix 3. Selected examples of medication ‘side-effects’ in the words of participants  
Medicine  Participants experiences  
Alzheimer’s tablet ‘rather loose to the toilet’ 
Beta-blocker ‘they paralysed me.  I couldn’t move my arms more 
than that in about two weeks’ 
Citalopram ‘made my head fuzzy’ 
‘I hear myself talking’ 
Codeine ‘upsets my stomach’ 
Gabapentin ‘they give me constipation’ 
Prednisolone ‘they made me very, very depressed’ 
Statin ‘pain in my thigh and numbness of the digits’ 
‘pains in my calves and leg muscles’ 
Tegretol ‘tiredness and the awful slothfulness’  
 
 
